Atlas Trials

Reduced Intensity Conditioning (RIC) Regimen and Post-transplant Cyclophosphamide in Haploidentical Bone Marrow Transplantation in in Patients With Poor Prognosis Lymphomas

Clinical trial NCT02049580 · UNKNOWN

Trial details

NCT number
NCT02049580
Sponsor
Istituto Clinico Humanitas
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2013-07-01
Primary completion
2016-08-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.